873087-79-7 Usage
Uses
Used in Pharmaceutical Industry:
8,14β-Dihydrooripavine is used as an impurity in the production of Hydromorphone, an opioid analgesic, for the management of moderate to severe pain. Its presence in Hydromorphone is crucial for ensuring the quality, safety, and efficacy of the drug.
Used in Research and Development:
8,14β-Dihydrooripavine is utilized in research and development for the study of its chemical properties, potential applications, and interactions with other compounds. This research can contribute to the development of new drugs, therapies, and technologies in the pharmaceutical and healthcare industries.
Used in Quality Control and Analysis:
8,14β-Dihydrooripavine is employed in quality control and analysis processes to ensure the purity and consistency of Hydromorphone and other related compounds. Its detection and quantification in pharmaceutical products help maintain the safety and efficacy of these medications.
Used in Drug Synthesis:
8,14β-Dihydrooripavine may be used as an intermediate or precursor in the synthesis of other pharmaceutical compounds, including opioids and their derivatives. Its unique chemical properties can contribute to the development of new drugs with improved therapeutic profiles and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 873087-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,8 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 873087-79:
(8*8)+(7*7)+(6*3)+(5*0)+(4*8)+(3*7)+(2*7)+(1*9)=207
207 % 10 = 7
So 873087-79-7 is a valid CAS Registry Number.
873087-79-7Relevant academic research and scientific papers
PROCESSES FOR MAKING HYDROCODONE, HYDROMORPHONE AND THEIR DERIVATIVES
-
Paragraph 0089; 0090, (2015/09/28)
Improved processes for making hydrocodone and hydromorphone as well as their 8,14-dihydrothebaine and 8,14-dihydrooripavine derivatives and salts are disclosed.
PROCESSES FOR MAKING HYDROCODONE, HYDROMORPHONE AND THEIR DERIVATIVES
-
Page/Page column 21; 22, (2015/09/28)
Improved processes for making hydrocodone and hydromorphone as well as their 8,14-dihydrothebaine and 8,14-dihydrooripavine derivatives and salts are disclosed.
Methods for Producing Hydrocodone, Hydromorphone or a Derivative Thereof
-
Page/Page column 13, (2011/04/18)
The present disclosure generally relates to methods for producing opioid derivatives. More particularly, the present disclosure relates to the preparation of hydromorphone, hydrocodone, or a derivative thereof, by means of a non-catalytic hydrogenation reaction of thebaine, oripavine or a derivative thereof, respectively, using a hydrazide reagent, followed by hydrolysis of the hydrogenated intermediate at a low temperature and for a short period of time. Additionally, the present disclosure relates to a composition comprising the desired hydromorphone, hydrocodone, or a derivative thereof, in combination with a 6-beta compound that is structurally related thereto.
Process for the synthesis of hydromorphone
-
Page/Page column 6, (2008/06/13)
There is described a method for converting oripavine to hydromorphone or a physiologically acceptable salt thereof such as hydromorphone hydrochloride involving generation of 8,14-dihydrooripavine utilising diimine.
